Results 11 to 20 of about 7,344,621 (307)
Taking a multidisciplinary perspective (including public health, sociology, criminology, and political science amongst others) and using examples from across the globe, this book provides a detailed understanding of the complex and highly contested nature of drug policy, drug policy making, and the theoretical perspectives that inform the study of drug
Ritter, Alison ; https://orcid.org/ +1 more
core +4 more sources
Decolonizing drug policy. [PDF]
Abstract This paper reviews evidence of how drug control has been used to uphold colonial power structures in select countries. It demonstrates the racist and xenophobic impact of drug control policy and proposes a path to move beyond oppressive systems and structures.
Daniels C +8 more
europepmc +6 more sources
Drug Use and Drug Policy [PDF]
Early in the twentieth century the Dutch East Indies (present-day Indonesia) had a government monopoly on the import, refining, and retailing of opium. There were regional differences in opium policy ranging from areas with prohibition to areas where opium use was hardly restricted.
Luijk, Eric W. van, Ours, Jan C. van
openaire +3 more sources
The Europeanization of UK drug policy: transnational policy networks and evidence based policy-making [PDF]
The European Union (EU) has significantly increased its formal competencies in the area of drug policy since the Treaty of European Union (TEU) yet in practice drug policies remain varied from state to state. It is said that a European approach to drugs
Standring, Adam John
core +6 more sources
To provide a detailed overview of the recent reforms in pharmaceutical pricing and reimbursement processes as well as in other important areas of the pharmaceutical policy in Greece.Information was collected via a structured questionnaire. The study used publicly available resources, such as publications, relevant legislation, and statistical data ...
Yfantopoulos, J.N., Chantzaras, A.
openaire +3 more sources
The aim of this article was to present a general overview of the health care system as well as pricing and reimbursement environment in Estonia. In Estonia the main stakeholders in the pharmaceutical sector are the Ministry of Social Affairs, the State Agency of Medicine, and the Estonian Health Insurance Fund.
Kadri, Mägi +2 more
openaire +2 more sources
We present a brief overview of the health care system in Hungary, focusing particularly on the pricing and reimbursement procedures of medicines. The National Institute of Health Insurance Fund Management is responsible for the administration of the health insurance system and public reimbursement of health technologies.
András, Inotai +3 more
openaire +2 more sources
We present a general overview of the health care system as well as the pricing and reimbursement environment in Latvia. Overall, the pharmaceutical sector in Latvia, including pricing and reimbursement, is strictly regulated. The main Latvian stakeholder in the pharmaceutical sector is the Ministry of Health.
Janis, Silins, Monika, Szkultecka-Dębek
openaire +2 more sources
We presented a general overview of the health care system as well as the pricing and reimbursement environment in Poland. Poland aims to ensure proper access to safe and effective medicines while reducing patients' share in treatment costs. Nevertheless, the co-payment for pharmacotherapy is still high (more than 60%). The key policymaker and regulator
Karina Jahnz-Różyk +3 more
openaire +3 more sources
The objectives of this article were to describe the characteristics of the drug policy in Romania in the last 10 years and to present the consequences in terms of patient accessibility to drugs.The Romanian health care system with pricing and reimbursement legislation was studied while considering the evolution of pricing and reimbursement processes ...
Ciprian-Paul, Radu +2 more
openaire +2 more sources

